 |
| Rus |  |
Eng |  |
The workshop in NTUU KPI and report of American professor Sergey Lyshevski, Rochester University, USA on microelectromechanical (MEMS) and bio-microelectromechanical (BioMEMS) systems, microsystems nano-technologies and their applications, Kiev, NTUU KPI, October 18, 2012
In his report Sergey Lyshevski talked on possible fields of advances in science, engineering and medicine applications considering the latest discoveries and advances in the field of MEMS and BioMEMS. In the professor’s opinion an integration of nano- and nano-biotechnologies takes place. The main attention was focused on MEMS and Microsystems development, designing, manufacturing and realization. MEMS technology enables reading, running and handling of the paradigms.
In prof. Lyshevski’s report physics and bio-physics of reading, measuring and handling of MEMS and BioMEMS were considered. The study objective was performing a number of testings on probing, running and processing of standards, study and approbation of first principles and developing of set of methods, approaches, technical skills and means which can be used for study of engineering, biological and bio-oriented systems. Considering of natural and engineering systems of bio- samples interaction and presentation, measuring and characterization of solving by means of nanoscale electronics and MEMS.
Part of report and workshop was devoted to application of MEMS, Microsystems and nanotechnologies in the countries with highly developed aerospace, automobile and military branches; energetic and electromechanical systems, microelectronics and robotics.
 |
 |
 |
| Professor Sergey Lyshevski presents his report on application of microelectromechanical systems and devices on their basis | Discussions of Prof. Lyshevski report |
Workshop and discussions of nanotechnologies and microsystems problems |
 |
 |
 |
| Materials Research Centre’s director Oleksiy Gogotsi at the workshop on mycrosystems, MEMS, NTUU KPU, October 18, 2012 | Materials Research Centre’s director Oleksiy Georgievich Gogotsi and prof. Lyshevski, Rochester university, USA in NTUU KPU, October 18, 2012 | From left to right: Vic Korsun, Слева направо: Вик Корсун, STCU’s Deputy Executive Director from USA, Materials Research Centre’s director Oleksiy Gogotsi, prof. Sergey Lyshevski, Rochester University, USA in NTUU KPI, October 18, 2012 |
 |
 |
 |
| Slides from the report presentation, presented by prof. Lyshevski | Informational slides on MEMS and bio-MEMS, prepared by the reporteur |
Slides from the presentation on nanotechnologies, micro- and bio-microelectrochemical devices and their application |
*Sergey Edward Lyshevski, Ph.D., Professor of Electrical Engineering
Department of Electrical and Microelectronic Engineering, Rochester Institute of Technology, Rochester, NY 14623-5603, USA
Related Items :
MXenes potential applications include sensors, wound healing materials, and drug delivery systems. A recent study explored how different synthesis methods affect the safety and performance of MXenes. By comparing etching conditions and intercalation strategies, researchers discovered that fine-tuning the surface chemistry of MXenes plays a crucial role in improving biocompatibility. These results provide practical guidelines for developing safer MXenes and bring the field one step closer to real biomedical applications.
Exellent news, our joint patent application with Drexel University on highly porous MAX phase precursor for MXene synthesis published. Congratulations and thanks to all team involved!
Last Call! Have you submitted your abstract for IEEE NAP-2025 yet? Join us at the International Symposium on "The MXene Frontier: Transformative Nanomaterials Shaping the Future" – the largest MXene-focused conference in Europe this year! Final Submission Deadline: May 15, 2025. Don’t miss this exclusive opportunity to showcase your research and engage with world leaders in the MXene field!
We are excited to announce the publication of latest review article on MXenes in Healthcare. This comprehensive review explores the groundbreaking role of MXenes—an emerging class of 2D materials—in revolutionizing the fields of medical diagnostics and therapeutics. Read the full article here: https://doi.org/10.1039/D4NR04853A.
Congratulations and thank you to our collaborators from TU Wien and CEST for very interesting work and making it published! In this work, an upscalable electrochemical MXene synthesis is presented. Yields of up to 60% electrochemical MXene (EC-MXene) with no byproducts from a single exfoliation cycle are achieved.
Congratulations to all collaborators with this interesting joint work!
Thank you to our collaborators for the amazing joint work recently published in Graphene and 2D Nanomaterials about MXene–silk fibroin composite films aiming to develop materials with tunable electronic and thermal properties
Dr. Oleksiy Gogotsi, director of MRC and Carbon-Ukraine, innovative companies that are among the leaders on the world MXene market, visited 2024 MRS Fall Meeting & Exhibit. together with Dr. Maksym Pogorielov, Head of Advanced Biomaterials and Biophysics Laboratory, University of Latvia.
MRC and Carbon-Ukraine team visited the 3rd International MXene conference held at Drexel University on August 5-8, 2024. Conference brought together the best reserchers and leading experts on MXene field. 
Together with colleagues from the University of Latvia, MRC/Carbone Ukraine, Adam Mickiewicz University, University Clinic Essen, and others, we have developed a novel concept involving the binding of antibodies to MXenes. In our research, we utilized anti-CEACAM1 antibodies to develop targeted photo-thermal therapy for melanoma (in vitro), paving the way for future in vivo studies and clinical trials. For the first time, we demonstrate the feasibility of delivering MXenes specifically targeted to melanoma cells, enabling the effective ablation of cancer cells under near-infrared (NIR) light. This new technique opens up vast potential for the application of MXenes in cancer treatment, diagnostics, drug delivery, and many other medical purposes.
